Intellectual Property India Publishes Patent Application for 'Tumor Microenvironment-Activated Antibody-drug Conjugates Employing Selectively Cleavable Linkers For Targeted Cancer Therapy' Filed by Panipat Institute Of Engineering And Technology

MUMBAI, India, Feb. 6 -- Intellectual Property India has published a patent application (202511131983 A) filed by Panipat Institute Of Engineering And Technology, Samalkha, Haryana, on Dec. 26, 2025, for 'tumor microenvironment-activated antibody-drug conjugates employing selectively cleavable linkers for targeted cancer therapy.'

Inventor(s) include Prof. Parveen Kumar Goyal; Dr. Preeti Garg; and Dr. Gaurav Agarwal.

The application for the patent was published on Feb. 6, under issue no. 06/2026.

According to the abstract released by the Intellectual Property India: "The present invention discloses tumor microenvironment-activated antibody-drug conjugates comprising an antibody or antigen-binding fragment, a cytotoxic or therapeutic payl...